Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

Feigin, Valery L.; Lawes, Carlene M.M.; Bennett, Derrick; Barker‐Collo, Suzanne; Parag, Varsha

doi:10.1016/s1474-4422(09)70025-0

Cited by 2,442 publications

(1,898 citation statements)

References 99 publications

Supporting

Mentioning

1,729

Contrasting

Unclassified

Order By: Relevance

“…Case fatality rates due to stroke vary around the world (Feigin, Lawes, Bennett, Barker‐Collo, & Parag, 2009) and depend on the severity of stroke, the subtype of stroke and other factor (Coull et al., 2004; Eliasziw et al., 2004; Eriksson & Olsson, 2001; Evans, Harraf, Donaldson, & Kalra, 2002; Evans, Perez, Yu, & Kalra, 2000; Feigin et al., 2009; Jackson & Sudlow, 2005; de Jong, Lodder, Kessels, & van Raak, 2004; Norrving, 2003; Vaartjes, O'Flaherty, Capewell, Kappelle, & Bots, 2013; Yokota, Minematsu, Hasegawa, & Yamaguchi, 2004). Stroke mortality has decreased in many countries, but the incidence has not (Feigin et al., 2009; Vaartjes et al., 2013).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Secondary prophylactic treatment and long‐term prognosis after TIA and different subtypes of stroke. A 25‐year follow‐up hospital‐based observational study

Eriksson

2016

Brain and Behavior

View full text Add to dashboard Cite

ObjectivesTo assess long‐term prognosis after transient ischemic attack (TIA)/subtypes of stroke relative to secondary prophylactic treatment(s) given.Materials and MethodsRetro/prospective follow‐up of patients hospitalized in the Stroke Unit or in the Department of Neurology, Linköping, in 1986 and followed up to Feb. 2011.ResultsA total of 288 men were followed up for 2254 years (mean 7.8 years) and 261 women for 1984 years (mean 7.6 years). In men, the distribution to anticoagulants (AC) (warfarin treatment) was 18%, antiplatelet therapy (APT) usually ASA 75 mg/day 54%, untreated 27%, unknown 2%. In women, the distribution to AC was 15%, APT 60%, untreated 23%, unknown 2%, respectively. Mortality rates at 1 year, 10 years, and 25 years for men were 21%, 67%, and 93%, respectively, versus the rates in women of 24%, 71%, and 90%, respectively. Survival curves showed markedly increased risk of death compared to the normal population. AC treatment was more favorable for men regarding the annual risk of stroke, compared with APT (9.4% vs. 9.8%), as well as the risks of MI, (5.6% vs. 6.7%), and death (8.1% vs. 10.3%), compared to women for stroke (11.6% vs. 8.8%) and MI (5.3% vs. 3.7%) but not for death (8.3% vs. 8.4%). The risk of fatal bleeding was 0.86% annually on AC compared to 0.17% on APT. According to Cox regression analysis included patients with TIA/ischemic stroke, first‐line treatment had beneficial effects on survival: AC OR 0.67 (0.5–0.9), APT 0.67 (0.52–0.88) versus untreated.ConclusionsPatients with a history of TIA/stroke had a higher mortality rate versus controls, providing support for both primary and secondary prophylaxis regarding vascular risk factors for death. This study also provided support for secondary prophylactic treatment with either AC or ASA (75 mg once daily) to reduce the vascular risk of death unless there are contraindications.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Stroke mortality has decreased in many countries, but the incidence has not (Feigin et al., 2009; Vaartjes et al., 2013). Ten treatable risk factors have been associated with 90% of the risk of ischemic or hemorrhagic stroke (O'Donnell et al., 2010).…”

Section: Discussionmentioning

confidence: 99%

Secondary prophylactic treatment and long‐term prognosis after TIA and different subtypes of stroke. A 25‐year follow‐up hospital‐based observational study

Eriksson

2016

Brain and Behavior

View full text Add to dashboard Cite

show abstract

“…47,48 Conflicting conclusions have been reached among patients with SAH and ICH, although trends have probably been favourable. [49][50][51][52][53] There are relatively few corresponding Canadian data. A recent large national study involving more than 13,000 patients who had been resuscitated and hospitalized following cardiac arrest did not detect any improvements in survival rates over time.…”

Section: Discussionmentioning

confidence: 99%

Declining mortality in neurocritical care patients: a cohort study in Southern Alberta over eleven years

Kramer

Zygun

2013

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

“…In general, the trends in stroke incidence and mortality rates have decreased in the recent decades for high-income countries such as the U.S., the United Kingdom, and Canada [83][84][85][86]. Analyses from the Framingham Study revealed a decrease in stroke incidence for the past 50 years, although the lifetime risk of stroke did not decrease to the same degree [86]; this may reflect both an improvement in risk factor control, as well as an improvement in life expectancy.…”

Section: Trends In Strokementioning

confidence: 99%

Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy

2011

View full text Add to dashboard Cite

Stroke is the fourth killer and number one cause of adult disability in the United States. The estimated direct and indirect costs of stroke care in this country are $68.9 billion for 2009. The prevalence of stroke and its cost will undoubtedly rise as the aging population increases. In addition, stroke incidence and mortality are increasing in less developed countries in which the lifestyles and population restructuring are rapidly changing. More population-based research to assess incidence, risk factors, and outcomes are needed in these countries. Epidemiologic studies can help identify groups of individuals or regions at higher risk for stroke. They can also help us better understand the natural history of certain conditions and therefore push the direction of therapeutic investigations. Furthermore, the study of trends across different time periods and different populations can help investigators evaluate the effects of stroke care programs and treatment options.

show abstract

Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

Cited by 2,442 publications

References 99 publications

Secondary prophylactic treatment and long‐term prognosis after TIA and different subtypes of stroke. A 25‐year follow‐up hospital‐based observational study

Secondary prophylactic treatment and long‐term prognosis after TIA and different subtypes of stroke. A 25‐year follow‐up hospital‐based observational study

Declining mortality in neurocritical care patients: a cohort study in Southern Alberta over eleven years

Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy

Contact Info

Product

Resources

About